Imaging as a biomarker for therapy response: Cancer as a prototype for the creation of research resources

Clinical Pharmacology and Therapeutics

Volumn 84, Issue 4, 2008, Pages 433-436

  McLennan, G ^a   Clarke, L ^b   Hohl, R J ^a  

^a UNIVERSITY OF IOWA   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER DIAGNOSIS; CANCER THERAPY; COMPUTER ASSISTED TOMOGRAPHY; CORRELATION ANALYSIS; DIFFUSION WEIGHTED IMAGING; DIGITAL IMAGING; DISEASE COURSE; EDITORIAL; IMAGING; MOLECULAR BIOLOGY; MOLECULAR IMAGING; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ANALYSIS; TREATMENT RESPONSE; X RAY;

DATABASES, FACTUAL; HUMANS; INTERDISCIPLINARY COMMUNICATION; LUNG NEOPLASMS; MAGNETIC RESONANCE IMAGING; NATIONAL CANCER INSTITUTE (U.S.); NEOPLASMS; PROGRAM DEVELOPMENT; RADIOLOGY INFORMATION SYSTEMS; RESEARCH DESIGN; UNITED STATES;

EID: 56449119838     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2008.171     Document Type: Editorial

References (14)

1. National Cancer Institute. Report of the Clinical Trials Working Group of the National Cancer Advisory Board: Restructuring the National Cancer Clinical Trials Enterprise 〈http://integratedtrials.nci.nih.gov/ict/ CTWG_report_June2005.pdf〉 (June 2005).
2. US Food and Drug Administration. FDA's Critical Path Initiative 〈http://www.fda.gov/oc/initiatives/criticalpath〉 (2008).
3. 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute trials. J. Nucl. Med. 47, 1059-1066 (2006) 〈http://jnm.snmjournals.org/cgi/reprint/47/6/1059〉.
4. National Cancer Institute. Cancer Imaging Program. Magnetic Resonance 〈http://imaging.cancer.gov/reportsandpublications/ReportsandPresentations/ MagneticResonance〉.
5. National Cancer Institute. Cancer Imaging Program. Lung Imaging Database Consortium (LIDC) 〈http://imaging.cancer.gov/programsandresources/ InformationSystems/LIDC〉.
6. Foundation for the National Institutes of Health. Imaging Database Resources Initiative (IDRI) 〈http://www.nihfoundation.org/partners/ research_environment/IDRI.shtml〉 (9 September 2005).
7. National Cancer Institute. National Cancer Imaging Archive 〈http://ncia.nci.nih.gov/collections〉.
8. Association of American Cancer Institutes. RIDER Database Resource and Plans for a Public Private Partnership 〈http://www.aaci-cancer.org/irats/ pdfs/rider.pdf〉
9. Armato, S.G. III et al. The Reference Image Database to Evaluate Response to Therapy in lung cancer (RIDER) project: a resource for the development of change-analysis software. Clin. Pharmacol. Ther. 84, 448-456 (2008)
10. National Institute of Standards and Technology. U.S. Measurement System. USMS Workshops. Imaging as a Biomarker: Standards for Change Measurements in Therapy, 14-15 September 2006, NIST Gaithersburg, Maryland 〈http://usms. nist.gov/workshops/bioimaging.htm〉.
11. Association of American Cancer Institutes. The IRAT Network. Imaging Response Assessment Teams 〈http://www.aaci-cancer.org/irats/index. asp〉.
12. National Cancer Institute. caBIG Cancer Biomedical Informatics Grid. In Vivo Imaging (IMAG) Workspace 〈https://cabig.nci.nih.gov/ workspaces/Imaging〉.
13. National Cancer Institute. Quantitative Imaging for Evaluation of Responses to Cancer Therapies (U01) 〈http://grants.nih.gov/grants/guide/pa- files/PAR-08-225.html〉.
14. Suter, M.J., Reinhardt, J.M. & McLennan, G. Integrated CT/ bronchoscopy in the central airways: preliminary results. Acad. Radiol. 15, 786-798 (2008).